FindTrial
Sign In

Dose-finding study of AJG533 in patients with chronic constipation (Phase 2 study)

Dose-finding study of AJG533 in patients with chronic constipation (Phase 2 study)

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222557
Enrollment
Unknown
Registered
2014-07-09
Start date
2014-07-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic constipation

Interventions

investigational material(s) Generic name etc : AJG533 INN of investigational material : elobixibat Therapeutic category code : 235 Purgatives and clysters Dosage and Administration for Investigational

Sponsors

AJINOMOTO PHARMACEUTICALS CO.,LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with chronic constipation

Exclusion criteria

Exclusion criteria: Patient with known or suspected organic constipation Patient with known or suspected symptomatic constipation or drug-induced constipation

Design outcomes

Primary

MeasureTime frame
Frequency of Spontaneous Bowel Movement—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026